LENOVO
31.7.2024 15:01:34 CEST | Business Wire | Press release
Today, Lenovo has joined forces with Databricks to drive AI adoption amongst its customers. As a Databricks Consulting & Systems Integration (C&SI) Select Tier Partner, Lenovo will work with businesses to help them take advantage of enhanced data management capabilities, streamlining access to data from multiple sources and removing barriers to successful AI usage.
The offering will run through the Lenovo AI Center of Excellence (AI CoE), designed to help customers put AI to work for their organizations quickly, cost-effectively and at scale, with solutions that bring AI from ideation to reality. Working with the Databricks Data Intelligence Platform, Lenovo will help businesses to bring their data sources together, allowing them to increase the use of generative AI, improve their data analytics capabilities and drive innovation. The Lenovo AI Center of Excellence (AI CoE) will provide services to help customers define outcomes and rapidly innovate with the Databricks Platform to meet the unique needs of their organization.
“We’ve spoken to many customers at various stages of their AI journeys and, while most want to reap the benefits and feel the urgency to do so, their organizations aren’t ready,” commented Linda Yao, Chief Operating Officer and Head of Strategy, Lenovo Solutions & Services Group. “Our latest study showed that 90% of the CIOs we surveyed see AI as a game changer, yet over half feel their organizations lack the technical skills to scale AI quickly. By adding Databricks to Lenovo's ecosystem of leading software vendors, we can further enable our AI for all vision and bring the technology to a broader set of customers."
Starting in the Greater China and Asia Pacific Region, then rolling out globally, Lenovo will offer end-to-end expertise in solutions and services for data management, including cloud, data and AI strategy, data platform modernization, data migration, pre-built code for quick implementation, optimization, governance and audit management, and AI and ML use cases.
"Our partnership with Lenovo showcases our unwavering commitment to democratize data and AI for all organizations. We are proud to see our relationship with Lenovo transform from customer to key partner. Together, we are driving unprecedented innovation, accelerating growth, and delivering exceptional value to our customers on the Databricks Data Intelligence Platform," said Greg Taylor, VP of Partners, Databricks.
Lenovo was awarded partner status due to its broad and deep expertise in IT solutions, including over 10 years of public cloud solutions practice and rich operational experience gained in more than 15 years of data platform construction. The new offering forms part of Lenovo’s comprehensive AI Services practice that provides training and tools to help customers maximize their use of AI.
Based on insights from the recent Lenovo CIO report, most organizations struggle with how to deploy AI-powered solutions quickly, effectively, and securely. To support customers globally, Lenovo announced a comprehensive AI services portfolio aligned with the Gartner® Five Critical AI Adoption Phases. The Lenovo AI CoE aims to accelerate these services and use cases to deliver faster outcomes and improve efficiency by harnessing AI to unlock the value of their data.
"With an experienced and expert team on hand, our collaboration with Databricks will accelerate AI readiness and move customers closer to responsible and efficient AI adoption,” added Art Hu, SVP & CIO for Lenovo, and Chief Technology and Delivery Officer for Lenovo’s Solutions and Services Group. "From architecture and data management, through to implementation and governance, we can provide end-to-end solutions that remove obstacles to AI integration and help customers get to the benefits at pace."
A relationship built on Lenovo’s own experience with the Databricks Platform
Lenovo’s work with Databricks builds on a relationship that started in 2022, with Lenovo creating its own enterprise-level global data warehouse through Databricks and fundamental Azure services. Incorporating corporate common data models and 200 core KPIs to date, the warehouse supports the breadth of the organization, from product and production to supply, sales and services.
With its experience in digital and intelligent transformation and now as an implementation partner for Databricks, Lenovo is able to provide data and AI solutions based on Lenovo’s Hybrid Cloud infrastructure. The Lenovo and Databricks collaboration means customers will benefit from a modern data platform with streamlined data governance to help them accelerate their enterprise reporting and analytics and the adoption of AI applications.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a pocket-to cloud portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
LENOVO is a trademark of Lenovo. All other trademarks are the property of their respective owners. ©2024 Lenovo Group Limited.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731568838/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom